Clinical Trial Update: Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain Injury [Phase 2]

View source ↗

Summary

Phase 2 trial update on complement inhibition for overshooting inflammation after traumatic brain injury, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Snippet

Sponsor: Leiden University Medical Center | Conditions: Traumatic Brain Injury, Trauma, Head | Phase 2 | Status: UNKNOWN